Buys
Open market- Shares
- Avg price
- Total value
Edward M. Basile - Director at TransMedics Group, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TMDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Edward M. Basile in TransMedics Group, Inc.
Sells
Open market- Shares
- -4,142
- Avg price
- $130.45
- Total value
- -$540,324
Net
Past year- Shares
- -4,142
- Share %
- -100%
- Total value
- -$540,324
Reported holdings for Edward M. Basile in TransMedics Group, Inc.
Form 4 holding
Director
TransMedics Group, Inc.
- Security class
- Common Stock
- Shares / value
- 5,788
- Estimated value
- $575,385
- Report date
- 20 May 2026
- Price
- $99.41
- Ownership
- Direct
Form 4 holding
Director
TransMedics Group, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 29 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Edward M. Basile in TransMedics Group, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.